Line 127: | Line 127: | ||
<p style="text-align:left"> Our team is proud to state that we conceived the idea for Maxed OOT and subsequently designed and carried out all experiments ourselves. That said, there are many advisors who we would like to thank for helping to provide continuous advice and support, because, without them, we would not have been able to have achieved our goals. You can read more about people, teams and companies who helped us <a href="https://2018.igem.org/Team:Edinburgh_UG/Attributions"> here. </a> </p> | <p style="text-align:left"> Our team is proud to state that we conceived the idea for Maxed OOT and subsequently designed and carried out all experiments ourselves. That said, there are many advisors who we would like to thank for helping to provide continuous advice and support, because, without them, we would not have been able to have achieved our goals. You can read more about people, teams and companies who helped us <a href="https://2018.igem.org/Team:Edinburgh_UG/Attributions"> here. </a> </p> | ||
<p style="text-align:left"> <b>Characterization / Contribution </b></p> | <p style="text-align:left"> <b>Characterization / Contribution </b></p> | ||
− | <p style="text-align:left"> | + | <p style="text-align:left"> We successfully participated in InterLab study <a href="https://2018.igem.org/Team:Edinburgh_UG/InterLab"> (link). </a> We performed and obtained successful results after performing both plate Reader and CFU and Flow Cytometry protocols. </p> |
+ | <p style="text-align:left"> Also, we characterised two parts from iGEM 2012 Paris Bettencourt. </p> | ||
+ | <div class="container"> | ||
+ | <table class="table"> | ||
+ | <thead> | ||
+ | <tr> | ||
+ | <th>Part number</th> | ||
+ | <th>Description</th> | ||
+ | <th>Supporting information</th> | ||
+ | |||
+ | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
+ | <tr> | ||
+ | <td> <a href="https://igem.org/2018_Judging_Form?team=Edinburgh_UG"> BBa_K914009</a></td> | ||
+ | <td>P1003* Ser133->Amber Codon</td> | ||
+ | <td> </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> <a href="http://parts.igem.org/Part:BBa_K914018"> BBa_K914018</a></td> | ||
+ | <td>P1003** Kan resistant gene with 2 Amber Codon</td> | ||
+ | <td> </td> | ||
+ | </tr> | ||
+ | |||
+ | </tbody> | ||
+ | </table> | ||
+ | </div> | ||
+ | |||
+ | |||
Revision as of 17:42, 17 October 2018
Medal Criteria
Bronze Medal Criteria
1 Registration and Giant Jamboree Attendance
We had a great iGEM season and see you all at the Giant Jamboree
2 Competition Deliverables
While reading our wiki, we hope you are excited to see our poser and presentation as well! You will find our Judging form here.
3 Attributions
Our team is proud to state that we conceived the idea for Maxed OOT and subsequently designed and carried out all experiments ourselves. That said, there are many advisors who we would like to thank for helping to provide continuous advice and support, because, without them, we would not have been able to have achieved our goals. You can read more about people, teams and companies who helped us here.
Characterization / Contribution
We successfully participated in InterLab study (link). We performed and obtained successful results after performing both plate Reader and CFU and Flow Cytometry protocols.
Also, we characterised two parts from iGEM 2012 Paris Bettencourt.
Part number | Description | Supporting information |
---|---|---|
BBa_K914009 | P1003* Ser133->Amber Codon | |
BBa_K914018 | P1003** Kan resistant gene with 2 Amber Codon |
Silver Medal Criteria
1 Validated Part / Validated Contribution
How we meet the criteria
2 Collaboration
How we meet the criteria
3 Human Practices
How we meet the criteria
Gold Medal Criteria
1 Integrated Human Practices
How we meet the criteria
2 Improve a Previous Part or Project
How we meet the criteria
3 Model Your Project
How we meet the criteria
4 Demonstration of Your Work
How we meet the criteria
Contact EdiGEM18
Feel free to leave us a comment on social media!